Modulatory role of nitric oxide in cardiac performance
Authors:
Open Access
- 1 January 2014
- journal article
- review article
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 67 (9-10) , 345-352
Abstract
Nitric oxide is produced by almost all cardiac cells, endothelial cells, cardiomyocytes and nerve fibers. It is synthesized by an enzyme, a nitric oxide synthase, which occurs in endothelial, neural and inducible form. The distribution of nitric oxide synthase in the heart is characterized by a pronounced non-uniformity. Nitric oxide exerts its effects in physiological and pathophysiological conditions. The physiological effects of low concentrations of nitric oxide, which is released in the normal conditions under the influence of constituent enzymes, occur via cyclic guanosine monophosphate. The synthesized nitric oxide exhibits its effect in the cells where it is produced, in an autocrine manner, or by diffusing into the neighboring cells, in a paracrine manner. Nitric oxide acts by regulating the coronary vessel tonus, affecting the contractility of cardiomyocytes, generating an inotropic effect in a dose-dependent manner and controlling the cellular respiration. Other effects of nitric oxide in the cardiovascular system include the hyperpolarization of the smooth muscle cells in blood vessels, the inhibition of the monocyte adhesion, the inhibition of platelet migration, adhesion and aggregation and the proliferation of smooth muscle cells and fibroblasts. The anti-atherosclerotic effects of nitric oxide are based on these effects. Nitric oxide is a weak free radical in gaseous state, and the cytotoxic and/or the cytoprotective effects of the higher concentrations of nitric oxide are related to the chemical structure of nitric oxide as a free radical. The excessive production of nitric oxide by the activation of inducible nitric oxide synthase can lead to major irregularities in the function of cardiomyocytes and cardiac insufficiency. Understanding the nitric oxide molecular mechanisms of signaling pathways in the heart can provide a new strategic approach to prevention and treatment of cardiovascular diseases.Keywords
This publication has 33 references indexed in Scilit:
- NOing the heart: Role of nitric oxide synthase-3 in heart developmentDifferentiation, 2012
- Canine Coronary Microvessel NO Production Regulates Oxygen Consumption in ecNOS Knockout Mouse HeartJournal of Molecular and Cellular Cardiology, 2000
- Paracrine and autocrine effects of nitric oxide on myocardial functionPharmacology & Therapeutics, 2000
- Regulation of cardiac β-adrenergic response by nitric oxideCardiovascular Research, 1999
- Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive ratCardiovascular Research, 1998
- Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat heartsEuropean Journal of Pharmacology, 1997
- Acute Effects of Nitric Oxide and Cyclic GMP on Human Myocardial ContractilityThe Journal of Pharmacology and Experimental Therapeutics, 1997
- Endothelial isoform of nitric oxide synthase in rat heart increases during developmentThe Anatomical Record, 1996
- Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathyThe Lancet, 1996
- Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxiaJournal of Molecular and Cellular Cardiology, 1995